Psychiatry was once big business for pharma, with drugs like Prozac making billions. Now a few breakthroughs are reviving ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on PDS Biotechnology (PDSB – Research Report) and Cartesian ...

Legend Biotech is building a new $150 million manufacturing plant, with its partner Johnson & Johnson, with the goal of ...

A new biotech is raising money to develop a drug believed to be capable of starving cancer cells, based on research out of a ...

Aurobindo, that last year signed a deal with U.S. drugmaker MSD to manufacture one of their biologics products at its subsidiary Theranym Biologics, has agreed on a contract to roll out a single ...

Scimplify has raised $40 million in a new equity round backed by Accel to expand its presence in the U.S. and enter new ...

Bristol-Myers Squibb acquires 2seventy bio for $286M, marking the end of a once-promising biotech. Check out if this is a ...

The third-place slot marked another return to form. Novo Nordisk’s Wegovy reclaimed the seat it held in December, backed by ...

Citi has initiated a 'buy' rating on Akums Drugs and Pharmaceuticals Ltd., citing consistent financial performance and market ...

Peethaambaran Kunnathoor, Chennai Wednesday, March 12, 2025, 08:00 Hrs [IST] ...

Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy ...

The company, through its directors, availed various working capital facilities from different banks under a consortium ...